During the past decade, SHI Sverdlovsk Regional Clinical Hospital #1;Neurology conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 6 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SHI Sverdlovsk Regional Clinical Hospital #1;Neurology" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "AO GENERIUM" with 2 trials sponsored, "R-Pharm International, LLC" with 2 trials sponsored, "TauRx Therapeutics Ltd" with 2 trials sponsored and "Actelion" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SHI Sverdlovsk Regional Clinical Hospital #1;Neurology" #1 collaborator was "OCT Clinical Trials" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Mene Research" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "SHI Sverdlovsk Regional Clinical Hospital #1;Neurology" are "Multiple Sclerosis" (3 trials), "Alzheimer's Disease" (2 trials), "Paroxysmal Nocturnal Hemoglobinuria" (2 trials), "Rheumatoid Arthritis" (2 trials) and "Anemia" (1 trials). Many other conditions were trialed in "SHI Sverdlovsk Regional Clinical Hospital #1;Neurology" in a lesser frequency.

Most popular intervention types in "SHI Sverdlovsk Regional Clinical Hospital #1;Neurology" are "Drug" (12 trials), "Biological" (2 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Ocrelizumab" (3 trials), "Antihistamine" (2 trials), "Methylprednisolone" (2 trials) and "Adalimumab 40mg q2w" (1 trials). Other intervention names were less common.

The vast majority of trials in "SHI Sverdlovsk Regional Clinical Hospital #1;Neurology" are 14 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "SHI Sverdlovsk Regional Clinical Hospital #1;Neurology". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in SHI Sverdlovsk Regional Clinical Hospital #1;Neurology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in SHI Sverdlovsk Regional Clinical Hospital #1;Neurology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".